(Q40402498)

English

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.

scientific article published on 12 December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

West Nile virus

0 references

vesicular stomatitis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Cristian Apetrei

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Konstantin G Kousoulas

10

object named as

Konstantin G Kousoulas

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Arun V Iyer

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marc J Boudreaux

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nobuko Wakamatsu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Alma F Roy

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Vladimir N Chouljenko

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Abolghasem Baghian

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Preston A Marx

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

12 December 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

893-903

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Structures of immature flavivirus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Conformational changes of the flavivirus E glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile virus infection: a pediatric perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

A fatal case of West Nile virus infection in a bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Transmission of West Nile virus from an organ donor to four transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile virus: pathogenesis and therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Skin manifestations of West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Characteristics of the rash associated with West Nile virus fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile virus neuroinvasive disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile virus infection: a new acute paralytic illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile encephalitis presenting as a stroke.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

The pathology of human West Nile Virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile virus encephalitis with myositis and orchitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Chorioretinal involvement in patients with West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Virology, pathology, and clinical manifestations of West Nile virus disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile virus: recent trends in diagnosis and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Yellow fever: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

A live, attenuated recombinant West Nile virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Vesicular stomatitis virus: re-inventing the bullet

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Development of a new vaccine for the prevention of Lassa fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

CD69 is an immunoregulatory molecule induced following activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Role of CD8+ T cells in control of West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

Acute pancreatitis in West Nile Fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.087

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term outcomes of human West Nile virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The West Nile Virus and the dialysis/transplant patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible dialysis-related west nile virus transmission--Georgia, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrauterine West Nile virus infection--New York, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attenuated vesicular stomatitis viruses as vaccine vectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transfusion-associated transmission of West Nile virus--Arizona, 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 Genome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of West Nile virus in blood donations--United States, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigations of West Nile virus infections in recipients of blood transfusions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

West Nile virus infection in organ donor and transplant recipients--Georgia and Florida, 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ChimeriVax-West Nile vaccine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects for development of a vaccine against the West Nile virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19070640

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2008.11.087

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19070640%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40402498&oldid=1541382321"